2025-09-26 10:09:03
2025-09-26 08:10:38
2025-09-26 08:06:15
2025-09-26 07:59:12
2025-09-26 03:46:01
2025-09-25 18:00:46
2025-09-25 12:57:25
2025-09-25 10:33:49
2025-09-25 00:30:33
2025-09-25 00:30:32
2025-09-24 20:00:13
2025-09-24 19:54:56
The Acute Intermittent Porphyria (AIP) market is witnessing dynamic shifts with ongoing advancements in treatment and diagnosis, driven by a growing understanding of rare metabolic disorders. Market Size and Overview The acute intermittent porphyria market is estimated to be valued at USD 1.52 Billion in 2025 and is expected to reach USD 2.33 Billion by 2032, growing at a compound annual...